Neoadjuvant systemic and intravesical chemotherapy with partial cystectomy for muscle invasive bladder cancer with concomitant CIS

Neoadjuvant systemic and intravesical chemotherapy with partial cystectomy for muscle invasive bladder cancer with concomitant CIS

The presence of carcinoma in situ (CIS) is traditionally a contraindication to bladder-sparing approaches for muscle invasive bladder cancer (MIBC). Strategies that might aid in bladder preservation for this population require further investigation. We report a case of MIBC with CIS treated with bot...

Full description

Bibliographic Details
Main Authors: Benjamin D. Plambeck, Tutku E. Tazegul, Ian M. McElree, Ryan L. Steinberg, Vignesh T. Packiam, Michael A. O'Donnell
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Urology Case Reports
Subjects:
Muscle invasive bladder cancer
Carcinoma in situ
Partial cystectomy
Gemcitabine
Docetaxel
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442023002024
Description
Summary:The presence of carcinoma in situ (CIS) is traditionally a contraindication to bladder-sparing approaches for muscle invasive bladder cancer (MIBC). Strategies that might aid in bladder preservation for this population require further investigation. We report a case of MIBC with CIS treated with both neoadjuvant systemic and intravesical chemotherapy prior to partial cystectomy.
ISSN:2214-4420

Similar Items